Zions Bancorporation’s Guardant Health GH Stock Holding History

Zions Bancorporation’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-180	Closed	-$7K	–	982
2022 Q2	$7K	Hold	180	–	–	﹤0.01%	798
2022 Q1	$12K	Hold	180	–	–	﹤0.01%	780
2021 Q4	$18K	Sell	180 -56	-24%	-$5.79K	﹤0.01%	633
2021 Q3	$30K	Buy	236 +56	+31%	+$6.65K	﹤0.01%	523
2021 Q2	$22K	Buy	+180	New	+$24.2K	﹤0.01%	565

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Zions Bancorporation's GH Position: Q3 2022 in Review

Zions Bancorporation sold out of Guardant Health (GH) in Q3 2022, closing a stake of 180 shares — an estimated $7K sold.

Zions Bancorporation first reported a position in GH in Q2 2021 and held it in 5 quarters. The position peaked at $30K in Q3 2021. 328 funds tracked by Wall St. Rank hold GH as of Q3 2022.

Zions Bancorporation reported no remaining Guardant Health position as of Q3 2022 after selling out during the quarter.
Zions Bancorporation sold 180 Guardant Health shares in Q3 2022, an estimated $7K.
Zions Bancorporation first reported a position in Guardant Health in Q2 2021 and held it in 5 quarters.
Zions Bancorporation's Guardant Health position peaked at $30K in Q3 2021.
328 funds tracked by Wall St. Rank held Guardant Health as of Q3 2022.

Based on Zions Bancorporation's 13F filing for Q3 2022, filed 8 Nov 2022.